Lista de obras -

A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer’s disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity

article by Sven J. van der Lee et al published 27 May 2019 in Acta Neuropathologica

A phase III randomized trial of gantenerumab in prodromal Alzheimer's disease

artículo científico publicado en 2017

ACE variants and risk of intracerebral hemorrhage recurrence in amyloid angiopathy

artículo científico publicado en 2010

Age and the association between apolipoprotein E genotype and Alzheimer disease: A cerebrospinal fluid biomarker-based case-control study

scientific article published on 20 August 2020

Alzheimer's disease risk variants modulate endophenotypes in mild cognitive impairment

artículo científico publicado en 2016

Analysis of shared heritability in common disorders of the brain

artículo científico publicado en 2018

Author Correction: GBA and APOE ε4 associate with sporadic dementia with Lewy bodies in European genome wide association study

artículo científico publicado en 2019

Author Correction: Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing

scientific article published on 01 September 2019

C9orf72, AAO and ancestry help discriminating behavioural from language variants in FTLD cohorts

scientific article published on 17 September 2020

CALHM1 P86L polymorphism is associated with late-onset Alzheimer's disease in a recessive model.

artículo científico publicado en 2010

Clinical Applicability of the Specific Risk Score of Dementia in Type 2 Diabetes in the Identification of Patients with Early Cognitive Impairment: Results of the MOPEAD Study in Spain

scientific article published on 24 August 2020

Common variants in Alzheimer's disease and risk stratification by polygenic risk scores

artículo científico publicado en 2021

Correction to: A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer's disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity

scientific article published on 18 January 2020

Correction to: A phase III randomized trial of gantenerumab in prodromal Alzheimer's disease

scholarly article published in Alzheimers Research & Therapy

Different inflammatory signatures based on CSF biomarkers relate to preserved or diminished brain structure and cognition

Erratum to "Exploratory analysis of seven Alzheimer's disease genes: disease progression" [Neurobiol. Aging 34 (2013) 1310.e1-1310.e7].

artículo científico publicado en 2014

Estrogen receptor alpha gene variants are associated with Alzheimer's disease.

artículo científico publicado en 2010

Exploratory analysis of seven Alzheimer's disease genes: disease progression

artículo científico publicado en 2012

Frontotemporal dementia and its subtypes: a genome-wide association study

artículo científico publicado en 2014

GBA and APOE ε4 associate with sporadic dementia with Lewy bodies in European genome wide association study

artículo científico publicado en 2019

GOLPH2 gene markers are not associated with Alzheimer's disease in a sample of the Spanish population.

artículo científico publicado en 2009

Gene-wide analysis detects two new susceptibility genes for Alzheimer's disease

artículo científico publicado en 2014

Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing

artículo científico publicado en 2019

Genetic study of neurexin and neuroligin genes in Alzheimer's disease.

artículo científico publicado en 2013

Investigation of c9orf72 in 4 neurodegenerative disorders

artículo científico publicado en 2012

Long runs of homozygosity are associated with Alzheimer's disease

artículo científico publicado en 2021

MMP-2/MMP-9 plasma level and brain expression in cerebral amyloid angiopathy-associated hemorrhagic stroke.

artículo científico publicado en 2011

Molecular evaluation of human Ubiquilin 2 gene PXX domain in familial frontotemporal dementia patients

article

Prioritization of Drug Targets for Neurodegenerative Diseases by Integrating Genetic and Proteomic Data From Brain and Blood

artículo científico publicado en 2023

Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease

artículo científico publicado en 2017

Rare mutations in SQSTM1 modify susceptibility to frontotemporal lobar degeneration

artículo científico publicado en 2014

Rare nonsynonymous variants in SORT1 are associated with increased risk for frontotemporal dementia

artículo científico publicado en 2018

Reliable Measurements of theβ-Amyloid Pool in Blood Could Help in the Early Diagnosis of AD ⬇️

artículo científico publicado el 16 de agosto de 2012

Several Direct and Calculated Biomarkers from the Amyloid-β Pool in Blood are Associated with an Increased Likelihood of Suffering from Mild Cognitive Impairment ⬇️

artículo científico publicado el 1 de enero de 2013

TBK1 Mutation Spectrum in an Extended European Patient Cohort with Frontotemporal Dementia and Amyotrophic Lateral Sclerosis

scientific article published on 23 December 2016

The CALHM1 P86L polymorphism is a genetic modifier of age at onset in Alzheimer's disease: a meta-analysis study

artículo científico publicado en 2010

The membrane-spanning 4-domains, subfamily A (MS4A) gene cluster contains a common variant associated with Alzheimer's disease.

artículo científico publicado en 2011

Transdermal Is Better than Oral: Observational Research of the Satisfaction of Caregivers of Patients with Alzheimer’s Disease Treated with Rivastigmine ⬇️

artículo científico publicado el 9 de enero de 2013

Lista de obras de

A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer’s disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity

A phase III randomized trial of gantenerumab in prodromal Alzheimer's disease

ACE variants and risk of intracerebral hemorrhage recurrence in amyloid angiopathy

Age and the association between apolipoprotein E genotype and Alzheimer disease: A cerebrospinal fluid biomarker-based case-control study

Alzheimer's disease risk variants modulate endophenotypes in mild cognitive impairment

Analysis of shared heritability in common disorders of the brain

Author Correction: GBA and APOE ε4 associate with sporadic dementia with Lewy bodies in European genome wide association study

Author Correction: Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing

C9orf72, AAO and ancestry help discriminating behavioural from language variants in FTLD cohorts

CALHM1 P86L polymorphism is associated with late-onset Alzheimer's disease in a recessive model.

Clinical Applicability of the Specific Risk Score of Dementia in Type 2 Diabetes in the Identification of Patients with Early Cognitive Impairment: Results of the MOPEAD Study in Spain

Common variants in Alzheimer's disease and risk stratification by polygenic risk scores

Correction to: A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer's disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity

Correction to: A phase III randomized trial of gantenerumab in prodromal Alzheimer's disease

Different inflammatory signatures based on CSF biomarkers relate to preserved or diminished brain structure and cognition

Erratum to "Exploratory analysis of seven Alzheimer's disease genes: disease progression" [Neurobiol. Aging 34 (2013) 1310.e1-1310.e7].

Estrogen receptor alpha gene variants are associated with Alzheimer's disease.

Exploratory analysis of seven Alzheimer's disease genes: disease progression

Frontotemporal dementia and its subtypes: a genome-wide association study

GBA and APOE ε4 associate with sporadic dementia with Lewy bodies in European genome wide association study

GOLPH2 gene markers are not associated with Alzheimer's disease in a sample of the Spanish population.

Gene-wide analysis detects two new susceptibility genes for Alzheimer's disease

Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing

Genetic study of neurexin and neuroligin genes in Alzheimer's disease.

Investigation of c9orf72 in 4 neurodegenerative disorders

Long runs of homozygosity are associated with Alzheimer's disease

MMP-2/MMP-9 plasma level and brain expression in cerebral amyloid angiopathy-associated hemorrhagic stroke.

Molecular evaluation of human Ubiquilin 2 gene PXX domain in familial frontotemporal dementia patients

Prioritization of Drug Targets for Neurodegenerative Diseases by Integrating Genetic and Proteomic Data From Brain and Blood

Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease

Rare mutations in SQSTM1 modify susceptibility to frontotemporal lobar degeneration

Rare nonsynonymous variants in SORT1 are associated with increased risk for frontotemporal dementia

Reliable Measurements of theβ-Amyloid Pool in Blood Could Help in the Early Diagnosis of AD ⬇️

Several Direct and Calculated Biomarkers from the Amyloid-β Pool in Blood are Associated with an Increased Likelihood of Suffering from Mild Cognitive Impairment ⬇️

TBK1 Mutation Spectrum in an Extended European Patient Cohort with Frontotemporal Dementia and Amyotrophic Lateral Sclerosis

The CALHM1 P86L polymorphism is a genetic modifier of age at onset in Alzheimer's disease: a meta-analysis study

The membrane-spanning 4-domains, subfamily A (MS4A) gene cluster contains a common variant associated with Alzheimer's disease.

Transdermal Is Better than Oral: Observational Research of the Satisfaction of Caregivers of Patients with Alzheimer’s Disease Treated with Rivastigmine ⬇️